181 results on '"Cherniak R"'
Search Results
2. Multiplicity in the Structure of the Glucuronoxylomannan of Cryptococcus Neoformans
3. 2780 Surgical Coaching in Obstetrics and Gynecology: A Multi-Centre Pilot ProjecT
4. Multiplicity in the Structure of the Glucuronoxylomannan of Cryptococcus Neoformans
5. Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication
6. Multipurpose mobile power means for AIP
7. Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure
8. Two year prognosis of sarcoidosis: the ACCESS experience
9. Mannoprotein from Cryptococcus neoformans promotes T-helper Type 1 anticandicidal responses in mice
10. Role of mannoprotein in induction and regulation of immunity to C. neoformans
11. ChemInform Abstract: Structural Characterization of the Galactoxylomannan of Cryptococcus neoformans Cap67.
12. Cryptococcus neoformansand its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure
13. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies
14. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
15. Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene
16. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay
17. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells
18. Serotyping of Cryptococcus neoformans by dot enzyme assay
19. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay
20. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis
21. Polysaccharide antigens of the capsule of Cryptococcus neoformans
22. Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay
23. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A
24. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen
25. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and b13C-nuclear magnetic resonance spectroscopy
26. Galactoxylomannans of Cryptococcus neoformans
27. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans
28. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan
29. Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide inCryptococcus neoformans
30. Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans.
31. Capsular polysaccharide of Clostridium perfringens Hobbs 9
32. Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.
33. Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis
34. Capsular polysaccharides of Clostridium perfringens Hobbs 5
35. Artificial neural networks in chemotype analysis of Cryptococcus neoformans.
36. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.
37. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
38. Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy
39. Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 5 as determined by NMR spectroscopy
40. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
41. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens
42. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.
43. Common polysaccharide antigens from the cell envelope of Clostridium perfringens type A
44. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies
45. Immunochemical evidence for multiple serotypes of Bacteroides fragilis
46. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer- simulated artificial neural network
47. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A
48. Localization of mannoprotein in Cryptococcus neoformans
49. RESPIRATION IN HEALTH AND DISEASE
50. OBESITY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.